At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Patient-led surveillance +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised Controlled Pilot Trial of Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.
In Brief
A clinical study evaluating Patient-led surveillance and Clinician-led surveillance for Melanoma (Skin). Completed, enrolled 100 participants across 3 sites.
Detailed Summary
The purpose of this pilot study is to evaluate digitally supported skin self-examination compared to usual care in people treated for localised melanoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMelanoma (Skin)
CountriesAustralia
CollaboratorsMelanoma and Skin Cancer Trials Limited
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 2018
Enrollment StartNov 2018
Primary CompletionFeb 2020
TodayJul 2026
First PostedJul 10, 2018
Enrollment StartNov 1, 2018
Primary CompletionFeb 17, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.0 years ago
Interventions
Patient-led surveillancedevice
Usual care plus reminders, ASICA instructional videos, a mobile dermatoscope, an app that facilitates store-and-forward teledermatology, and fast-tracked unscheduled clinic visits.
Clinician-led surveillancebehavioral
Usual care (scheduled clinician visits)